Chula Vista's ProSciento allies with Spanish biotech on liver diseases

Chula Vista's ProSciento allies with Spanish biotech on liver diseases


Seeking to advance clinical trials on liver diseases, ProSciento , a clinical services provider based in Chula Vista, has signed a multi-year partnership with the Spanish biotechnology company Owl Metabolomics . The alliance seeks to identify people who are eligible for clinical trials of therapies for nonalcoholic fatty liver disease, or NAFLD, along with a more serious complication, nonalcoholic steatohepatitis, or NASH.



from Biotech News